Healthpeak Properties, Inc. (NYSE:DOC) Given Consensus Rating of “Hold” by Brokerages

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have earned an average recommendation of “Hold” from the thirteen analysts that are currently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $19.4167.

Several equities research analysts recently commented on the stock. Robert W. Baird cut their price objective on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. The Goldman Sachs Group began coverage on Healthpeak Properties in a report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price target on the stock. Evercore decreased their price objective on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Finally, Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds have recently modified their holdings of DOC. Norges Bank acquired a new stake in shares of Healthpeak Properties in the fourth quarter valued at about $153,550,000. JPMorgan Chase & Co. grew its stake in Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its position in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after purchasing an additional 4,776,056 shares during the last quarter. Finally, Equity Investment Corp raised its stake in shares of Healthpeak Properties by 209.6% during the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock worth $102,088,000 after purchasing an additional 3,608,849 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

NYSE DOC opened at $16.70 on Tuesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The stock has a market cap of $11.60 billion, a price-to-earnings ratio of 166.97, a PEG ratio of 8.96 and a beta of 1.12. The business has a 50 day simple moving average of $16.79 and a 200 day simple moving average of $17.55. Healthpeak Properties has a 52-week low of $15.71 and a 52-week high of $21.28.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same quarter in the previous year, the firm posted $0.46 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a yield of 7.3%. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.